Voters in South Dakota are poised to approve two separate ballot measures next month that would legalize marijuana and allow patients to access medical cannabis.
Articles
Drop in political funding by MPP illustrates shift toward marijuana trade groups, MSOs
The Marijuana Policy Project has long been a leader in funding cannabis reform at the state and federal levels, but the current election season demonstrates that MPP’s role is shifting in a significant way – toward a more collaborative position with industry trade associations and large MJ companies.
The 4 Best-Performing Psychedelic Stocks
As the new rally in psychedelic stocks progresses, these four companies are currently setting the pace.
USDA Approves New Mexico Hemp Plan
The U.S. Department of Agriculture has approved New Mexico’s hemp planwhich will take effect for growers licensed after October 31.
Shawn Kemp Opening Seattle’s First Black-Owned Dispensary
Former National Basketball Association (NBA) star Shawn Kemp is opening Seattle, Washington’s first Black-owned cannabis dispensary on October 30. Kemp, drafted by the Seattle Supersonics in the first round of the 1989 draft, played for the team until 1997 and was a six-time NBA All-Star and three-time All-NBA selection.
Montana Supreme Court Rejects Lawsuit to Block Legalization Initiative
The Montana Supreme Court has rejected a challenge by Wrong for Montana against the ballot initiative to legalize adult-use cannabis sales in the state, MTPR reports.
Pennsylvania House Votes To Protect Medical Marijuana Patients From DUI Charges
The Pennsylvania House of Representatives approved an amendment on Tuesday that would protect medical marijuana patients from being penalized under the state’s DUI laws for using their legal medicine.
Nine Members Of Congress Tell DEA To Revise Proposed Hemp Rule On THC Content
Nine members of Congress sent a letter to the Drug Enforcement Administration (DEA) on Tuesday, urging the agency to revise its proposed hemp regulations.
How and Why Psychedelic Drugs Can Conquer The Mental Health Crisis
An enormous Crisis. Huge treatment markets. Massive disruption potential. Welcome to the psychedelic drug industry.
Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms
Numinus announces its first psilocybin harvest and the appointment of a new Science Officer.
Colorado marijuana vape aerosol testing rules address key health issues
As they respond to the 2019 vaping health crisis, Colorado marijuana regulators are believed to be among the first in the nation to require cannabis vaporizer companies to test the aerosol produced when the oil is heated into vapor.
Field Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago
Field Trip Health opens a new clinic in Chicago, its 4th ketamine-assisted psychotherapy clinic.
Mind Cure’s New Medtech Platform Is A Critical Puzzle-Piece
With its new digital therapeutics platform, Mind Cure is positioning itself as an emerging leader in the psychedelic drug industry.
Psyched Wellness Ltd. to Commence Trading on the CSE on October 22, 2020
The latest psychedelic drug company to commence public trading is Psyched Wellness.
Mind Cure Announces LOI for Acquisition of Epiphany360 Digital Therapeutics Platform for Treating Mental Health
Mind Cure has acquired Epiphany360, a digital therapeutics platform for the treatment of mental health conditions.